Europe SPECT Equipment Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Type (Hybrid SPECT (SPECT-CT and SPECT-MR) and Standalone SPECT), Radioisotope Type (Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and Other Radioisotopes), Application (Seizures, Stroke, Stress Fractures, Infections, Tumors, and Others), and End User (Hospitals, Imaging Centers, and Others)


No. of Pages: 149    |    Report Code: TIPRE00027132    |    Category: Life Sciences

Europe SPECT Equipment Market
Buy Now

The SPECT equipment market in Europe is expected to grow from US$ 398.87 million in 2021 to US$ 525.36 million by 2028; it is estimated to grow at a CAGR of 4.0% from 2021 to 2028.

 

Gallium-67 is of a gold standard for tumour diagnosis and staging. Hybrid imaging using Ga-67 SPECT/CT enables the localization of lymphoma lesions. Ga-67 is a primarily used agent for the imaging of inflammation, because it has the ability to accumulate non-specifically in inflamed areas as a metal-transferrin complex, followed by further binding to transferrin receptors. Some of the market players, which provide Gallium Citrate GA-67 are Lantheus Medical Imaging and Mallinckrodt Nuclear. Diagnostic imaging has gained a significant role in the management of patients who are suffering from cancer and has made an additional step forward with the introduction of fusion techniques into the field. SPECT technology provides hybrid images of two independent modalities, a functional scintigraphic technique and an anatomical procedure, yielding a superior imaging study. Scintigraphy is based on the use of single-photon or positron-emitting tracers providing a description of function or processes, whereas computed tomography (CT), ultrasound, or magnetic resonance imaging (MRI) depict the precise localization and type of morphological changes that have occurred in the lesions. The recent introduction of a hybrid imaging device containing a low dose CT system and a gamma camera on a single gantry enabled the sequential acquisition of the two imaging modalities, with the subsequent merging of data into a composite image display.

 

Countries in the European regions were greatly affected due to the COVID-19 pandemic, particularly diagnostic practice. According to the findings published on PubMed, the pandemic posed a significant challenge to NM departments, and every center in Europe witnessed a workforce loss. To prevent COVID-19 transmission, NM agencies implemented restrictions such as postponing non-high-priority procedures. Due to COVID-19, several departments encountered delays in receiving radiopharmaceuticals, which are used in SPECT equipment, as well as technical help. As a result, the pandemic reduced the number of diagnostic and therapeutic NM operations performed, as well as the degree of care provided to patients with diseases other than COVID-19, such as cancer or acute cardiovascular disease. According to the results of the British Nuclear Medicine Society (BNMS) COVID-19 survey, around 97% of NM departments introduced procedures to limit SARS-CoV-2 transmission; at 68% of sites, standardized operating procedures were developed for running departments in pandemic situations. As per the global survey by Freudenberg et al., around 15% of the respondent departments modified working hours for less than 20% of the staff and reported a mean decline of 54.4% in diagnostic procedures. Nuclear scans decreased by a mean of 36%; thyroid scans decreased by 67%; myocardial studies by 66%; bone scans by 60%; lung scans by 56%; and sentinel lymph node procedures by 45%. Nearly all (97%) participating centers in the survey from Germany, Austria, and Switzerland reported a decline in diagnostic NM procedures. In addition, nuclear cardiology was one of the most affected branches of NM during the COVID-19 pandemic in the region. All non-urgent examinations were postponed, and a decrease in 32% and 31% of activity was observed in NHS England PET/CT services in April and May 2020, respectively. Apart from this, new findings supporting COVID-19 diagnosis are expected to accelerate the growth of SPECT Equipment in the region. With the role of SPECT in the COVID-19, the research studies can also pave the way in combating other epidemics in the future.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SPECT equipment market. The Europe SPECT equipment is expected to grow at a good CAGR during the forecast period.

 

 Europe SPECT Equipment Market Revenue and Forecast to 2028 (US$ Million)

 Europe SPECT Equipment Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report

Europe SPECT Equipment Strategic Insights

Strategic insights for the Europe SPECT Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-spect-equipment-market-strategic-framework.webp
Get more information on this report

Europe SPECT Equipment Report Scope

Report Attribute Details
Market size in 2021 US$ 398.87 Million
Market Size by 2028 US$ 525.36 Million
Global CAGR (2021 - 2028) 4.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Hybrid SPECT
  • Standalone SPECT
By Radioisotope Type
  • Iodine-123
  • Technetium-99m
  • Xenon-133
  • Thallium-201
  • Radium-223
  • Gallium-66
  • Other Radioisotopes
By Application
  • Seizures
  • Stroke
  • Stress Fractures
  • Infections
  • Tumors
By End User
  • Hospitals
  • Imaging Centers
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Bracco Imaging S.p.A.
  • Bruker Corporation
  • Cardinal Health, Inc
  • Curium
  • Lantheus Medical Imaging Inc.
  • Mediso Ltd.
  • MiE GmbH
  • NTP RADIOISOTOPES
  • Spectrum Dynamics Medical
  • Get more information on this report

    Europe SPECT Equipment Regional Insights

    The geographic scope of the Europe SPECT Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-spect-equipment-market-geography.webp
    Get more information on this report

    Europe SPECT Equipment Market Segmentation

     

    Europe SPECT Equipment Market – By

    Type

    • Hybrid SPECT
      • SPECT-CT
      • SPECT-MR
    • Standalone SPECT

    Europe SPECT Equipment Market – By Radioisotopes

    •  Iodine-123
    •  Technetium-99m
    •  Xenon-133
    •  Thallium-201
    •  Ra-223
    •  Ga-66
    •  Other Radioisotopes

    Europe SPECT Equipment Market – By Application

    • Seizures
    •  Stroke
    •  Stress Fractures
    •  Infections
    •  Tumors
    •  Others

    Europe SPECT Equipment Market – By End User

    • Hospitals
    •  Imaging Centers
    •  Others

    Europe SPECT Equipment Market- By Country

    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe

    Europe SPECT Equipment Market-Companies Mentioned

    • Bracco Imaging S.p.A.
    • Bruker Corporation
    • Cardinal Health, Inc
    • Curium
    • Lantheus Medical Imaging Inc.
    • Mediso Ltd.
    • MiE GmbH
    • NTP RADIOISOTOPES
    • Spectrum Dynamics Medical

    The List of Companies - Europe SPECT Equipment Market

    1. Bracco Imaging S.p.A.
    2. Bruker Corporation
    3. Cardinal Health, Inc
    4. Curium
    5. Lantheus Medical Imaging Inc.
    6. Mediso Ltd.
    7. MiE GmbH
    8. NTP RADIOISOTOPES
    9. Spectrum Dynamics Medical
    Frequently Asked Questions
    How big is the Europe SPECT Equipment Market?

    The Europe SPECT Equipment Market is valued at US$ 398.87 Million in 2021, it is projected to reach US$ 525.36 Million by 2028.

    What is the CAGR for Europe SPECT Equipment Market by (2021 - 2028)?

    As per our report Europe SPECT Equipment Market, the market size is valued at US$ 398.87 Million in 2021, projecting it to reach US$ 525.36 Million by 2028. This translates to a CAGR of approximately 4.0% during the forecast period.

    What segments are covered in this report?

    The Europe SPECT Equipment Market report typically cover these key segments-

    • Type (Hybrid SPECT, Standalone SPECT)
    • Radioisotope Type (Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, Other Radioisotopes)
    • Application (Seizures, Stroke, Stress Fractures, Infections, Tumors)
    • End User (Hospitals, Imaging Centers)

    What is the historic period, base year, and forecast period taken for Europe SPECT Equipment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe SPECT Equipment Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe SPECT Equipment Market?

    The Europe SPECT Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bracco Imaging S.p.A.
  • Bruker Corporation
  • Cardinal Health, Inc
  • Curium
  • Lantheus Medical Imaging Inc.
  • Mediso Ltd.
  • MiE GmbH
  • NTP RADIOISOTOPES
  • Spectrum Dynamics Medical
  • Who should buy this report?

    The Europe SPECT Equipment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe SPECT Equipment Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now